Pyrazole-Thiazole Core-Containing Analogs Exhibit Adjunctive Activity with Meropenem against Carbapenem-Resistant Enterobacteriaceae (CRE)

被引:3
|
作者
Kim, Chungsik [1 ]
Kassu, Mintesinot [1 ]
Smith, Kenneth P. [3 ]
Kirby, James E. [3 ]
Manetsch, Roman [1 ,2 ]
机构
[1] Northeastern Univ, Dept Chem & Chem Biol, 360 Huntington Ave, Boston, MA 02115 USA
[2] Northeastern Univ, Dept Pharmaceut Sci, 360 Huntington Ave, Boston, MA 02115 USA
[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
antibacterial activity; carbapenem-resistant enterobacteriaceae; adjunctive activity; meropenem; GRAM-NEGATIVE BACTERIA; BLOOD-STREAM; INFECTIONS; DESIGN; COMBINATION; DERIVATIVES; INHIBITORS;
D O I
10.1002/cmdc.202100321
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pyrazole-thiazole core-containing compound KP-40 and 20 novel derivatives were designed and synthesized through traditional SAR analysis. These molecules displayed adjunctive activity with meropenem against Gram-negative bacteria evidenced by a range of fractional inhibitory concentration (FIC=0.5-0.25) and minimum adjunctive concentration (MAC=128-32 mu M) values. Of this series of molecules, four compounds displayed notable adjunctive potential, with FIC and MAC values of 0.25 and 32 mu M, respectively. Moreover, the solubility of these compounds was improved to an acceptable range. Further analysis using our "in house" permeation and efflux multi parameter optimization (PEMPO) algorithm revealed key physicochemical properties that may be critical for the development of active Gram-negative antibacterials. Taking PEMPO scores into consideration prior to executing synthesis of analogs may be a simple, yet rapid and effective strategy that can be used in conjunction with traditional SAR approaches to aid in the design of potent Gram-negative antibacterials.
引用
收藏
页码:2775 / 2780
页数:6
相关论文
共 50 条
  • [31] In vivo study assessed meropenem and amikacin combination therapy against carbapenem-resistant and carbapenemase-producing Enterobacteriaceae strains
    Hagihara, Mao
    Kato, Hideo
    Yamashita, Rieko fff
    Soda, Midori
    Watanabe, Hiroki
    Sakanashi, Daisuke
    Shiota, Arufumi
    Asai, Nobuhiro
    Koizumi, Yusuke
    Suematsu, Hiroyuki
    Yamagishi, Yuka
    Kitaichi, Kiyoyuki
    Mikamo, Hiroshige
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (01) : 1 - 7
  • [32] TP0586532, a Novel Non-Hydroxamate LpxC Inhibitor: Potentiating Effect on In Vitro Activity of Meropenem against Carbapenem-Resistant Enterobacteriaceae
    Yoshida, Ippei
    Takata, Iichiro
    Fujita, Kiyoko
    Takashima, Hajime
    Sugiyama, Hiroyuki
    MICROBIOLOGY SPECTRUM, 2022, 10 (03):
  • [33] In Vitro Activity of Neomycin, Streptomycin, Paromomycin and Apramycin against Carbapenem-Resistant Enterobacteriaceae Clinical Strains
    Hu, Ya
    Liu, Lu
    Zhang, Xiaoxia
    Feng, Yu
    Zong, Zhiyong
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [34] Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae - Identification of LYS228
    Reck, Folkert
    Bermingham, Alun
    Blais, Johanne
    Capka, Vladimir
    Cariaga, Taryn
    Casarez, Anthony
    Colvin, Richard
    Dean, Charles R.
    Fekete, Alex
    Gong, Wanben
    Growcott, Ellie
    Guo, Hongqiu
    Jones, Adriana K.
    Li, Cindy
    Li, Fengxia
    Lin, Xiaodong
    Lindvall, Mika
    Lopez, Sara
    McKenney, David
    Metzger, Louis
    Moser, Heinz E.
    Prathapam, Ramadevi
    Rasper, Dita
    Rudewicz, Patrick
    Sethuraman, Vijay
    Shen, Xiaoyu
    Shaul, Jacob
    Simmons, Robert L.
    Tashiro, Kyuto
    Tang, Dazhi
    Tjandra, Meiliana
    Turner, Nancy
    Uehara, Tsuyoshi
    Vitt, Charles
    Whitebread, Steven
    Yifru, Aregahegn
    Zang, Xu
    Zhu, Qingming
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (04) : 748 - 755
  • [35] The synergic and addictive activity of biogenic silver nanoparticle associated with meropenem against carbapenem-resistant Acinetobacter baumannii
    Allend, Suzane Olachea
    Oliveira Garcia, Marcelle
    da Cunha, Kamila Furtado
    de Albernaz, Deborah Trota Farias
    Panagio, Luciano Aparecido
    Nakazaro, Gerson
    Reis, Guilherme Fonseca
    Oliveira, Thais Larre
    Neto, Amilton Clair Pinto Seixas
    Hartwig, Daiane Drawanz
    JOURNAL OF APPLIED MICROBIOLOGY, 2024, 135 (03)
  • [36] Meropenem-Vaborbactam Activity against US Multidrug-Resistant Enterobacterales Strains, Including Carbapenem-Resistant Isolates
    Shortridge, Dee
    Kantro, Valerie
    Castanheira, Mariana
    MICROBIOLOGY SPECTRUM, 2023, 11 (01)
  • [37] Activity of Imipenem-Relebactam and Comparator Agents against Genetically Characterized Isolates of Carbapenem-Resistant Enterobacteriaceae
    Canver, Matthew C.
    Satlin, Michael J.
    Westblade, Lars F.
    Kreiswirth, Barry N.
    Chen, Liang
    Robertson, Amy
    Fauntleroy, Kathy
    La Spina, Marisa
    Callan, Katrina
    Jenkins, Stephen G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (09)
  • [38] In Vitro Synergistic Activity of Sulbactam in Combination with Imipenem, Meropenem and Cefoperazone Against Carbapenem-Resistant Acinetobacter baumannii Isolates
    Dagi, Hatice Turk
    Kus, Halit
    Arslan, Ugur
    Tuncer, Inci
    MIKROBIYOLOJI BULTENI, 2014, 48 (02): : 311 - 315
  • [39] In vitro and in vivo activity of meropenem plus avibactam against MBL-producing carbapenem-resistant Klebsiella pneumoniae
    Li, Xiuyun
    Chen, Zhaowen
    Jiao, Jin
    Wang, Shifu
    Wang, Yuehua
    Wu, Weiwei
    Yang, Huijun
    Lou, Hongxiang
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023, 21 (01) : 91 - 98
  • [40] Captopril potentiated meropenem activity against MBL-producing carbapenem-resistant Klebsiella pneumoniae: in vitro and in vivo study
    Zhao, Dongmei
    Li, Hongru
    Yue, Chengcheng
    Sun, Kaili
    Dai, Yuanyuan
    Zhang, Hui
    Liu, Yanyan
    Gao, Yufeng
    Li, Jiabin
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2021, 218